Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 2 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Breast Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Glioblastoma 2 Carcinoma, Non-Small-Cell Lung 2 Astrocytoma 2 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Thrombocytosis 1 Sarcoma, Ewing 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplasms, Neuroepithelial 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1

Interventions

Temozolomide 22 Bevacizumab 10 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Irinotecan 5 Carmustine 4 fluorodopa F 18 3 Topotecan 3 Surgical Procedures, Operative 3 Standard of Care 3 Radiosurgery 3 Magnetic Resonance Imaging 3 Congresses as Topic 3 Carboplatin 3 Aminolevulinic Acid 3 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3 ribociclib 2 poly ICLC 2 fluoromisonidazole 2 carmustine, poliferprosan 20 drug combination 2 cabozantinib 2 Vorinostat 2 TIC10 compound 2 Re-Irradiation 2 Radiotherapy, Intensity-Modulated 2 Panobinostat 2 O(6)-benzylguanine 2 Melphalan 2 Lomustine 2 Lacosamide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Glioma × palbociclib × Clear all

NCT01227434 2015-07-17

PD0332991

University of California, San Francisco

Phase 2 Terminated

23 enrolled 8 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡